Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJessup, C.en
dc.contributor.authorBrereton, H.en
dc.contributor.authorSykes, P.en
dc.contributor.authorThiel, M.en
dc.contributor.authorCoster, D.en
dc.contributor.authorWilliams, K.en
dc.identifier.citationInvestigative Ophthalmology & Visual Science, 2005; 46(5):1675-1681en
dc.descriptionCopyright © 2005 by the Association for Research in Vision and Ophthalmologyen
dc.description.abstractPURPOSE. Allograft rejection is the leading cause of corneal graft failure. CD4+ T cells control the allograft response and represent targets for antirejection therapy. The purpose of this study was to transfer cDNA encoding a monomeric anti-CD4 antibody fragment to donor corneal endothelium, to attempt to modulate orthotopic corneal allograft rejection in the rat. METHODS. A replication-deficient adenoviral vector (AdV) encoding anti-CD4 single-chain, variable-domain antibody fragment (scFv) and enhanced green fluorescent protein (eGFP) was constructed (AdCD4GFP). AdV encoding eGFP alone (AdGFP) was used as a control. Transgenic product was detected by reverse transcription–polymerase chain reaction (RT-PCR), Western blot, flow cytometry, and fluorescence microscopy. The alloinhibitory capacity of anti-rat CD4 scFv was measured in the one-way mixed lymphocyte reaction (MLR). The survival of Wistar-Furth corneas transduced with AdV either immediately or 3 days before orthotopic transplantation in Fischer 344 recipients was examined. RESULTS. ScFv and eGFP mRNAs were detected in rat corneas transduced in vitro, and active scFv secreted in corneal supernatants peaked at days 4 to 5 after transduction at 23 ± 4 ng of protein per cornea per day. Antibody and scFv against rat CD4 blocked alloproliferation in MLR. However, transduction of corneas with AdCD4GFP ex vivo, immediately before transplantation, or in vivo, 3 days before transplantation, did not significantly prolong corneal allograft survival (P > 0.05). CONCLUSIONS. Anti-CD4 scFvs were capable of blocking allostimulation, but their local expression within the eye did not prolong corneal allograft survival, suggesting that sensitization may still occur.en
dc.description.statementofresponsibilityClaire F. Jessup, Helen M. Brereton, Pamela J. Sykes, Michael A. Thiel, Douglas J. Coster and Keryn A. Williamsen
dc.publisherAssoc Research Vision Ophthalmology Incen
dc.subjectCornea; CD4-Positive T-Lymphocytes; Animals; Rats, Inbred F344; Rats, Inbred WF; Rats; Adenoviridae; Immunoglobulin Variable Region; Luminescent Proteins; Green Fluorescent Proteins; Recombinant Fusion Proteins; RNA, Messenger; Microscopy, Fluorescence; Lymphocyte Culture Test, Mixed; Blotting, Western; Corneal Transplantation; Transplantation, Homologous; Flow Cytometry; Gene Transfer Techniques; Cell Proliferation; Graft Rejection; Graft Survival; Genetic Vectors; Single-Chain Antibodiesen
dc.titleLocal gene transfer to modulate rat corneal allograft rejectionen
dc.typeJournal articleen
pubs.library.collectionMedicine publicationsen
dc.identifier.orcidJessup, C. [0000-0003-1184-6653]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.